Oncotelic Therapeutics (OTLC) Receivables (2019 - 2026)
Oncotelic Therapeutics (OTLC) posted Receivables of $2,058 for Q2 2026, down 89.2% from $18,976 a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Oncotelic Therapeutics' Receivables came in at $51,324, up 170.5% from FY2024.
- Annual Receivables shows a five-year compound annual growth rate of -10.6% (FY2020 to FY2025).
- In prior years, Oncotelic Therapeutics' Receivables was $18,976 in FY2024 (unchanged), $18,976 in FY2023 (-3.9%), $19,748 in FY2022 (unchanged) and $19,748 in FY2021 (-78.0%).
- The Q2 2026 figure stands as the lowest quarterly Receivables in data going back to Q4 2019.
- On a year-over-year basis, Receivables increased in 1 of the last seven quarters, with growth averaging 0.3%.
- The strongest year-over-year quarter for Receivables in the past five years was Q4 2025, with growth of 170.5%; the weakest was Q2 2026, with a decline of 89.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | 2,058.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,058.00 |
| Dec 31, 2025 | 51,324.00 |
| Sep 30, 2025 | 3,976.00 |
| Jun 30, 2025 | 18,976.00 |
| Mar 31, 2025 | 18,976.00 |
| Dec 31, 2024 | 18,976.00 |
| Sep 30, 2024 | 18,976.00 |
| Jun 30, 2024 | 18,976.00 |
| Mar 31, 2024 | 18,976.00 |
| Dec 31, 2023 | 18,976.00 |
| Sep 30, 2023 | 18,976.00 |
| Jun 30, 2023 | 18,976.00 |
| Mar 31, 2023 | 19,748.00 |
| Dec 31, 2022 | 19,748.00 |
| Sep 30, 2022 | 19,748.00 |
| Jun 30, 2022 | 19,748.00 |
| Mar 31, 2022 | 19,748.00 |
| Dec 31, 2021 | 19,748.00 |
| Sep 30, 2021 | 69,806.00 |
| Jun 30, 2021 | 156,270.00 |
API Access
Oncotelic Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();